
Biocon’s biosimilar biz tops $4 bn in valuation
Abu Dhabi-based sovereign wealth fund ADQ has picked up 1.80% stake in Biocon Biologics for $75 million; The company already raised $255 million from global marquee investors last year.
Abu Dhabi-based sovereign wealth fund ADQ has picked up 1.80% stake in Biocon Biologics for $75 million; The company already raised $255 million from global marquee investors last year.
India is likely to recover faster than the rest of the world from the economic turmoil caused by Covid-19, with new opportunities presenting themselves, says Biocon chairperson.
An earlier judgment by the apex court making Coronavirus tests free across the board had sparked concerns over the viability of the private sector’s participation in testing for the virus.
The award recognises entrepreneurs who, with their disruptive ideas and passion for growth, are creating successful global enterprises.
The Budget rightly focusses on rural and agrarian growth, infrastructure creation, and a digital future, but misses out on a much-needed consumption boost.
The private equity firm’s investment values Biocon Biologics at about $3 billion on a pre-money equity basis.
Only around 6% companies on the Fortune India 500 list are managed by women.
The Fortune India MPW summit brings some of India’s biggest women executives together to discuss ideas and issues related to gender, women in the workplace, the economy, and the society at large.
Bengaluru-based Biocon’s portfolio of biologic drugs has grown rapidly in the last five years and the company wants it to be a $1 billion business by 2022.
Zia Mody, co-founder, AZB & Partners, tops this year’s Most Powerful Women in Business list, Kiran Mazumdar-Shaw, India’s biotech queen, is at No. 2. Here’s more about the list.